Prophylactic dextrose gel use in newborns at risk for hypoglycemia
J Perinatol. 2024 Oct 3. doi: 10.1038/s41372-024-02133-9. Online ahead of print. ABSTRACT OBJECTIVE: To assess the impact of prophylactic dextrose gel on short-term outcomes in …
Month: October 2024
Placental extracellular vesicles promote cardiomyocyte maturation and fetal heart development
Commun Biol. 2024 Oct 3;7(1):1254. doi: 10.1038/s42003-024-06938-4. ABSTRACT Congenital heart defects are leading causes of neonatal mortality and are often associated with placental abnormalities, but …
Multidisciplinary collaboration to improve neonatal kidney health
Nat Rev Nephrol. 2024 Oct 3. doi: 10.1038/s41581-024-00895-1. Online ahead of print. NO ABSTRACT PMID:39363019 | DOI:10.1038/s41581-024-00895-1
Development of maxillary sinuses in relation to the development of cranium in children on computed tomography imaging
Sci Rep. 2024 Oct 3;14(1):23005. doi: 10.1038/s41598-024-74586-z. ABSTRACT There are available studies assessing the development of maxillary sinuses in relation to the viscerocranium. However, there …
Changes in the intestinal microbiome of the preterm baby associated with stopping non-invasive pressure support: a prospective cohort study
BMJ Paediatr Open. 2024 Oct 3;8(1):e002675. doi: 10.1136/bmjpo-2024-002675. ABSTRACT BACKGROUND: Intestinal dysbiosis is implicated in the pathogenesis of necrotising enterocolitis and late-onset sepsis in preterm …
“An update on the approach to treatment of Sjogren’s Disease in pregnancy”
J Matern Fetal Neonatal Med. 2024 Dec;37(1):2411583. doi: 10.1080/14767058.2024.2411583. Epub 2024 Oct 3. ABSTRACT BACKGROUND: Women with Sjögren’s Disease are more likely to experience pregnancy …
Exploring the impact of gestational weight gain on maternal and infant health
Am J Clin Nutr. 2024 Oct;120(4):991-992. doi: 10.1016/j.ajcnut.2024.07.031. Epub 2024 Aug 28. NO ABSTRACT PMID:39362734 | DOI:10.1016/j.ajcnut.2024.07.031
The patient’s outcome, not the surgeon’s opinion, defines surgical success
Arch Dis Child. 2024 Oct 3:archdischild-2024-327768. doi: 10.1136/archdischild-2024-327768. Online ahead of print. NO ABSTRACT PMID:39362747 | DOI:10.1136/archdischild-2024-327768
A randomized controlled non-inferiority trial of placebo versus macrolide antibiotics for Mycoplasma pneumoniae infection in children with community-acquired pneumonia: trial protocol for the MYTHIC Study
Trials. 2024 Oct 3;25(1):655. doi: 10.1186/s13063-024-08438-6. ABSTRACT BACKGROUND: Mycoplasma pneumoniae is a major cause of community-acquired pneumonia (CAP) in school-aged children. Macrolides are the first-line …
Fragmentomics of plasma mitochondrial and nuclear DNA inform prognosis in COVID-19 patients with critical symptoms
BMC Med Genomics. 2024 Oct 4;17(1):243. doi: 10.1186/s12920-024-02022-2. ABSTRACT BACKGROUND: The mortality rate of COVID-19 patients with critical symptoms is reported to be 40.5%. Early …